SCHEMBL25174337

SCHEMBL25174337

Cc1cc2c(-c3ccc(F)cc3)nn(-c3ccc(OC(F)(F)F)cc3)c(=O)c2nc1C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
CACNA2D1 P54289 2/20 0.42
CACNA2D2 Q9NY47 1/20 0.42
TDP2 O95551 1/20 0.39
TRPV4 Q9HBA0 2/20 0.39
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPY5R Q15761 1/20 0.37
LMNA P02545 1/20 0.37
PPARD Q03181 3/20 0.37
NPBWR1 P48145 1/20 0.37
MCHR1 Q99705 1/20 0.37
TP53 P04637 2/20 0.36
PPARA Q07869 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25174338 0.91 LMNA (0.46) KDM4ENPSR1MAPTGAAMAPK1
SCHEMBL25479342 0.86 KDM4E (0.47) KDM4ENPSR1MAPTGAAMAPK1
SCHEMBL25479341 0.84 KDM4E (0.46) KDM4ENPSR1MAPTGAAMAPK1
SCHEMBL9228112 0.80 NPSR1 (0.58) KDM4ENPSR1MAPTGAAMAPK1
SCHEMBL9279562 0.79 NPSR1 (0.72) KDM4ENPSR1MAPTGAAMAPK1
SCHEMBL9230980 0.78 NPSR1 (0.53) KDM4ENPSR1MAPTGAAMAPK1
SCHEMBL25479257 0.77 NPSR1 (0.49) KDM4ENPSR1MAPTGAAMAPK1
SCHEMBL30442001 0.77 NPSR1 (0.44) KDM4ENPSR1MAPTGAATDP2
SCHEMBL25187350 0.77 NPSR1 (0.44) KDM4ENPSR1MAPTGAATDP2
SCHEMBL25188509 0.73 GAA (0.41) KDM4ENPSR1GAALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4429663-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS Vigil Neuroscience, Inc. (US) 2024-09-18 EP disclosed
WO-2023086799-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS VIGIL NEUROSCIENCE, INC. (US) 2023-05-19 WO disclosed
WO-2023086799-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS VIGIL NEUROSCIENCE, INC. (US) 2023-05-19 WO disclosed